There might be many treatment options for a cancer patients, but each one has its limitations. Also, a physician has a challenge in determining the best treatment method for an individual. However, a research team from Berkeley Lab has devised a system by which these decision are easier to make based in the genetic factors of the patients. The researcher have based this system on 14 genes that are known to overexpress in different types of cancer. By using these biomarkers, the test will be able to determine the best treatment for the patient, according to the probability of response a patient might have for the treatment selected. These are preliminary results, and the research team is probing further to improve confidence of their results.